Vitamin D Deficiency and Link to Osteoporosis to be Highlighted at Arab Health 2012

DUBAI, UAE, December 19, 2011 /PRNewswire/ --


International expert to share learnings at Middle East Orthopedics Conference as part of Arab Health 2012

 

Reports from the American University of Beirut Medical Centre have concluded that The Middle East and Africa region has the highest incidence of osteoporosis in the world, while UAE-based studies from the Emirates Osteoporosis Society (EOS) across Emiratis and expatriates show that one third of people in the UAE over the age of 50 suffer from osteoporosis. The society's findings also conclude that 78% of the UAE population, most notably Emirati women, suffer from Vitamin D deficiency, which is essential for good bone health, despite the abundance of sunshine.

The society confirms that lack of the essential vitamin in this part of the world can be as a result of limited sun exposure due to local cultural practices and the high outdoor temperatures, conservative clothing, urbanization, darker skin pigmentation, smoking, obesity, diet and prolonged breast feeding without supplements, high caffeine and carbonated consumption, as well as a lack of vitamin D fortification in common foods.

The subject will  be explored further at the eighth Middle East Orthopedics Conference taking place at Arab Health Exhibition & Congress from 23rd- 26th January 2012 in Dubai.  The conference will also address issues around orthopedics in the neonate, adolescent, senior patient, back patient and athlete as well as innovations and other topics pertinent to the region.

Mario Skugor, M.D., Co-Director, Endocrinology and Reproductive Organ Block, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland Clinic, Ohio, USA will be hosting a session on The Role of Vitamin D in Bone Health at the conference. Commenting on the issue he said, "Vitamin D deficiency is a critical concern in the Middle East and the prevalence of osteoporosis in the UAE and across the region demonstrates a clear need for change. In highlighting the issue during the conference, we aim to improve both awareness and education and highlight the disease as a national health priority alongside obesity and diabetes."

Women in the UAE's extreme lack of exposure to sunlight means that vitamin D deficiency could reach startling levels with serious consequences in the near future, "Education is a critical first step in addressing the problem" commented Simon Page, Managing Director - Life Sciences, Informa Exhibitions - the organisers of Arab Health. "The Middle East Orthopedics Conference provides a strong platform for delivery of the message across healthcare professionals from all over the region while supporting the work and findings of the International Osteoporosis Foundation."

Recommendations from the International Osteoporosis Foundation suggest bone health can be improved through the intake of vitamin D, regular and safe exposure to sunlight, a calcium and protein rich diet and supplements where necessary, and daily weight-bearing  and muscle strengthening exercise.  

For more information about the Middle East Orthopedics Conference at Arab Health, please visit http://www.ahcongress.com  or call +971-4-407-2743.

The Arab Health Exhibition and Congress is organised by Informa Exhibitions and provides a platform for the world's leading manufacturers, wholesalers and distributors to meet the medical and scientific community in the Middle East and beyond. Overall the Arab Health Exhibition and Congress will feature more than 3,000 exhibiting companies from 70 countries and is expected to attract around 70,000 participants.

Note to Editors

About Informa Exhibitions:

For more information about Informa Exhibitions, please visit http://www.informaexhibitions.com.

About Cleveland Clinic:

For more information about Cleveland Clinic, please visit http://www.myclevelandclinic.org.

For media enquiries please contact:
Haneen Aweidah
Account Executive
Hill & Knowlton
T: +971-4-3344930
[email protected]


SOURCE Arab Health

Suggested Articles

Gilead Sciences has found a new chief financial officer in an appointment that has mergers and acquisitions written all over it.

Pfizer's role as the hero in ramping up production of a chemo drug badly needed by pediatric oncologists is a turnabout for the drugmaker.

Johnson & Johnson is dealing with $2 billion in patent losses in 2019, but has 10 drugs growing at double-digit percentages, executives said Tuesday.